Rufinamide Suspension
Product Images NDC 31722-688

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 31722-688). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rufinamideoscamberlogo (Rufinamideoscamberlogo)

FDA Label Image

Rufinamideoscartonlabel (Rufinamideoscartonlabel)

Rufinamide Oral Suspension 40 mg/mL carton packaging from Camber Pharmaceuticals, Inc. The label indicates the oral suspension form, strength of 40 mg/mL, and volume of 460 mL. Instructions specify shaking the bottle before use and dispensing with accompanying medication guide. The label includes storage instructions and manufacturer information.*

FDA Label Image

Rufinamideoschemicalstructure (Rufinamideoschemicalstructure)

Chemical structure of Rufinamide, showing its molecular arrangement including fluorine-substituted aromatic ring and amide functional group.*

FDA Label Image

Rufinamideoscontainerlabel (Rufinamideoscontainerlabel)

Rufinamide Oral Suspension 40 mg/mL in a 460 mL bottle, labeled by Camber Pharmaceuticals, Inc. The label includes usage instructions, storage conditions of 20° to 25°C, and discard instructions within 90 days after opening. It provides a U.S. contact number and website for the medication guide. The product is manufactured by Hetero Labs Limited, India, with a barcode displayed on the label.*

FDA Label Image

Rufinamideosfigurea (Rufinamideosfigurea)

An illustration labeled Figure A showing components of a medication dispensing kit for Rufinamide oral suspension. The diagram includes a bottle, a box, a bottle adapter, and two syringes, likely used for measuring and administering the suspension dosage.*

FDA Label Image

Rufinamideosfigureb (Rufinamideosfigureb)

Illustration labeled Figure B showing a hand holding a medicine bottle with an arrow above indicating to shake the bottle well. This likely demonstrates proper handling for an oral suspension medication.*

FDA Label Image

Rufinamideosfigurec (Rufinamideosfigurec)

An instructional diagram labeled Figure C showing a bottle adapter. The illustration depicts the adapter component used with a medication bottle, likely to facilitate dispensing or measuring the oral suspension.*

FDA Label Image

Rufinamideosfigured (Rufinamideosfigured)

An instructional illustration labeled Figure D showing a hand gripping and pressing down on the cap of a bottle, with a downward arrow indicating the action of pushing the cap to open or close the bottle.*

FDA Label Image

Rufinamideosfiguree (Rufinamideosfiguree)

Illustration of an oral dosing syringe showing volume measurements up to 20 mL, including a detailed view of the 15 to 20 mL graduations, used for accurate dosing of Rufinamide oral suspension.*

FDA Label Image

Rufinamideosfiguref (Rufinamideosfiguref)

An instructional illustration labeled Figure F showing a hand pressing down on a dosing syringe inserted into a bottle, indicating how to draw or administer a suspension dose.*

FDA Label Image

Rufinamideosfigureg (Rufinamideosfigureg)

An instructional illustration labeled Figure G showing a hand holding a syringe-like device with a dropper tip positioned over a container. A downward arrow beside the image indicates the motion or direction for dispensing the liquid, likely demonstrating how to use the oral suspension product Rufinamide.*

FDA Label Image

Rufinamideosfigureh (Rufinamideosfigureh)

An instructional diagram showing a hand holding an oral dosing syringe containing liquid medication. The plunger of the syringe is being adjusted to the 5 mL dosage mark, with an arrow and text indicating the measurement to the violet end of the plunger. This illustrates how to measure the correct dose of liquid suspension accurately.*

FDA Label Image

Rufinamideosfigurei (Rufinamideosfigurei)

Illustration showing the proper technique for administering Rufinamide oral suspension to a patient using an oral syringe. The image depicts a person placing the syringe in the mouth, indicating correct dosing for the liquid medication.*

FDA Label Image

Rufinamideosfigurej (Rufinamideosfigurej)

An instructional illustration showing the steps for using an oral syringe to administer liquid medication. The first panel depicts drawing liquid from a cup into the syringe by pulling the plunger up. The second panel shows dispensing the liquid by pressing down the plunger, with drops emerging from the syringe tip.*

FDA Label Image

Rufinamideosfigurek (Rufinamideosfigurek)

Illustration showing a hand opening a child-resistant cap on a bottle, demonstrating proper technique for opening the medication container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.